drugset / Trial / NCT01026389

Efficacy Evaluation of Dotarem Compared to Gadovist in the Diagnosis of Peripheral Arterial Disease

NCT01026389

Phase 4 Completed 189 enrolled Guerbet
RandomizedParallel-groupQuadruple-blindDiagnostic

Summary

This study is an efficacy evaluation of Dotarem®-enhanced magnetic resonance angiography (MRA) compared to Gadovist®-enhanced MRA in the diagnosis of clinically significant abdominal or lower limb arterial diseases.

Timeline

Start
2009-10
Primary completion
2011-06
Completion
2012-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Gadobutrol Diagnostic / imaging agent 0.1 unknown Intravenous
Subject Gadoterate meglumine Diagnostic / imaging agent 0.1 unknown Intravenous